Insider trade

Officer sold ~$2.19M of EXEL shares in the open market

Traded May 26, 2026 · Filed May 28, 2026

Why it stands out

Exelixis's Research and Development sold $2.19M of Exelixis shares. The filing references vesting of compensation awards.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Officer$1M+Pre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$2,187,758

Shares × reported transaction price

Timing vs results

21 days after results of May 5, 2026, 71 days before results of Aug 5, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	+4.4%	−2.5%	+6.9%
30 days	+7.5%	−2.0%	+9.6%
90 days	+9.5%	+1.9%	+7.5%

Past results only. Not a forecast.

Includes 405,966 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"), and the performance-based restricted stock unit award granted to the Reporting Person on March 31, 2025 ("One-Time Award PSUs"). Each RSU is the economic equivalent of one share of Common Stock and each One-Time Award PSU represents a contingent right to receive one share of Common Stock.

Scheduled in advanceFiled 4mo ago

Scheduled in advanceFiled 4mo ago

Filed 4mo ago

Traded May 27 · filed 2 days later

Compensation award — excluded from discretionary-purchase analysis.